A BAFF Ligand-Based CAR-T Cell Targeting Three Receptors and Multiple B Cell Cancers

Investigators developed a B cell-activating factor (BAFF) ligand-based CAR and generated BAFF CAR-T cells using a non-viral gene delivery method.